Personalis, Inc. (PSNL)
15.70
-0.16
(-0.98%)
USD |
NASDAQ |
Nov 13, 16:00
15.70
0.00 (0.00%)
After-Hours: 19:59
Personalis Enterprise Value : 1.565B for Nov. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 1.565B |
| November 11, 2026 | 1.576B |
| November 10, 2026 | 1.568B |
| November 09, 2026 | 1.575B |
| November 06, 2026 | 1.558B |
| November 05, 2026 | 1.532B |
| November 04, 2026 | 1.558B |
| November 03, 2026 | 1.554B |
| November 02, 2026 | 1.555B |
| October 30, 2026 | 1.561B |
| October 29, 2026 | 1.573B |
| October 28, 2026 | 1.581B |
| October 27, 2026 | 1.578B |
| October 26, 2026 | 1.568B |
| October 23, 2026 | 1.564B |
| October 22, 2026 | 1.561B |
| October 21, 2026 | 1.570B |
| October 20, 2026 | 1.574B |
| October 19, 2026 | 1.568B |
| October 16, 2026 | 1.543B |
| October 15, 2026 | 1.573B |
| October 14, 2026 | 1.570B |
| October 13, 2026 | 1.564B |
| October 12, 2026 | 1.559B |
| October 09, 2026 | 1.581B |
| Date | Value |
|---|---|
| October 08, 2026 | 1.587B |
| October 07, 2026 | 1.581B |
| October 06, 2026 | 1.584B |
| October 05, 2026 | 1.624B |
| October 02, 2026 | 1.611B |
| October 01, 2026 | 1.599B |
| September 30, 2026 | 1.611B |
| September 29, 2026 | 1.564B |
| September 28, 2026 | 1.561B |
| September 25, 2026 | 1.576B |
| September 24, 2026 | 1.588B |
| September 23, 2026 | 1.564B |
| September 22, 2026 | 1.566B |
| September 21, 2026 | 1.553B |
| September 18, 2026 | 1.570B |
| September 17, 2026 | 1.552B |
| September 16, 2026 | 1.539B |
| September 15, 2026 | 1.538B |
| September 14, 2026 | 1.558B |
| September 11, 2026 | 1.550B |
| September 10, 2026 | 1.562B |
| September 09, 2026 | 1.570B |
| September 08, 2026 | 1.591B |
| September 04, 2026 | 1.655B |
| September 03, 2026 | 1.616B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Tempus AI, Inc. | 14.61B |
| 10X Genomics, Inc. | 7.271B |
| Alamar Biosciences, Inc. (California) | 2.022B |
| Champions Oncology, Inc. | 71.90M |
| Medpace Holdings, Inc. | 17.79B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -33.80M |
| Revenue (Quarterly) | 25.60M |
| Total Expenses (Quarterly) | 59.40M |
| EPS Diluted (Quarterly) | -0.3153 |
| Gross Profit Margin (Quarterly) | 25.67% |
| Profit Margin (Quarterly) | -132.1% |
| Earnings Yield | -7.40% |
| Normalized Earnings Yield | -7.400 |